The core activity of Dyverto AG is to support start-ups and young companies in the field of medical technology, particularly in the cardiovascular area. The company acts as an incubator and accelerator by identifying, developing and accompanying innovative ideas from clinical practice through patenting, prototyping and proof-of-concept phases. The goal is to transfer these ideas into new companies and secure venture capital financing.
AI-generated
Offering
Products & services
Industry:Research & Development
✓ Offered
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Platform for developing vascular rehabilitation technologies
Platform for developing vascular rehabilitation technologies, focusing on clinically and economically sustainable solutions to improve patient care.
Medical device for prevention of abdominal aortic aneurysms
Medical device for stabilising haemodynamics in early abdominal aortic aneurysms, with the aim of preventing disease progression before the critical size.
Versatile technology platform for cardiovascular and other applications
Patented technology platform with a self-expanding Nitinol multilayer design, designed for cardiovascular applications and potentially also beyond the Cardiovascular area.
Knowledge
No knowledge articles yet
Once Dyverto AG has claimed this profile, we'll publish editorial articles and case studies here together.